Minerva Neurosciences, Inc (NERV) financial statements (2021 and earlier)

Company profile

Business Address 1601 TRAPELO ROAD
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4688128833219
Cash and cash equivalents215026831419
Short-term investments2438102 18 
Restricted cash and investments000000
Prepaid expense121111
Total current assets:4790130843319
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment000000
Long-term investments and receivables  5   
Long-term investments  5   
Intangible assets, net (including goodwill)304949494949
Goodwill151515151515
Intangible assets, net (excluding goodwill)153434343434
Other noncurrent assets000   
Total noncurrent assets:304954494949
TOTAL ASSETS:771391841338368
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:322222
Accounts payable221111
Accrued liabilities0000 1
Employee-related liabilities  0 11
Taxes payable     0
Interest and dividends payable  000 
Other undisclosed accounts payable and accrued liabilities     (1)
Debt0 4511
Deferred revenue and credits   0
Other undisclosed current liabilities411320
Total current liabilities:7471054
Noncurrent Liabilities
Long-term debt and lease obligation0  49 
Long-term debt, excluding current maturities   49 
Operating lease, liability0
Liabilities, other than long-term debt434145131313
Deferred revenue and credits41   
Deferred revenue41
Contract with customer, liability41
Deferred tax liabilities, net 4131313
Deferred income tax liabilities2
Other liabilities 00  0
Other undisclosed noncurrent liabilities 4    
Total noncurrent liabilities:434545172213
Total liabilities:504952272717
Stockholders' equity
Stockholders' equity attributable to parent28901321065551
Common stock000000
Additional paid in capital315305296239157126
Accumulated deficit(287)(215)(164)(133)(102)(75)
Total stockholders' equity:28901321065551
TOTAL LIABILITIES AND EQUITY:771391841338368

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Operating expenses(76)(52)(41)(30)(26)(55)
Operating loss:(76)(52)(41)(30)(26)(55)
Nonoperating income121000
Investment income, nonoperating12100 
Foreign currency transaction gain (loss), before tax(0)(0)(0)(0)(0)0
Loss from continuing operations before equity method investments, income taxes:(74)(50)(40)(30)(26)(55)
Other undisclosed loss from continuing operations before income taxes (0)(1)   
Loss from continuing operations before income taxes:(74)(50)(41)(30)(26)(55)
Income tax benefit2 9   
Net loss:(72)(50)(32)(30)(26)(55)
Other undisclosed net loss attributable to parent   (1)(1) 
Net loss attributable to parent:(72)(50)(32)(31)(27)(55)
Other undisclosed net loss available to common stockholders, basic     (2)
Net loss available to common stockholders, diluted:(72)(50)(32)(31)(27)(57)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(72)(50)(32)(30)(26)(55)
Comprehensive loss, net of tax, attributable to parent:(72)(50)(32)(30)(26)(55)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: